In this regard, functional AQP3 and Nek2 is mutated or highly expressed in hepatocellular carcinoma, these molecular and cellular mechanisms may be overcome by the pharmacological action of AQP3/STAT3/CD133 pathway degradation and Nek2 inhibition. Here, AQP3 is linked to hepatocellular carcinoma.